Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18741628 | METHODS OF FORMING STORAGE STABLE MIXTURES | Non-Final OA | DSM IP Assets B.V. |
| 19209980 | PERSONAL CARE COMPOSITION SUBSTANTIALLY FREE OF ALKYL SULFATE OR ALKYL ETHER SULFATE TYPE OF SURFACTANTS | Non-Final OA | The Procter & Gamble Company |
| 18888534 | STRUCTURED RHEOLOGICAL SOLID PERSONAL CARE COMPOSITION | Non-Final OA | The Procter & Gamble Company |
| 19397956 | TREATMENT OF BLOOD LOSS AT TISSUE WOUND | Final Rejection | P Tech, LLC |
| 17539648 | COMPOSITE PARTICLES AND METHOD OF PRODUCING THE SAME, PERSONAL CARE PRODUCT, PERSONAL CARE PARTICLES AND METHOD OF PRODUCING THE SAME, PERSONAL CARE ARTICLE, AND PERSONAL CARE COMPOSITION | Final Rejection | TOPPAN INC. |
| 17043526 | FIBRIN-SPECIFIC MATERIALS AND METHODS OF USING THEREOF | Final Rejection | NORTH CAROLINA STATE UNIVERSITY |
| 17916180 | IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER | Non-Final OA | Washington University |
| 18894071 | POWDER COMPOSITION | Non-Final OA | AJINOMOTO CO., INC. |
| 17792694 | POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION OF BIOPROSTHETIC HEART VALVES | Non-Final OA | The Children's Hospital of Philadelphia |
| 18256304 | METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB | Final Rejection | HHT Foundation International, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy